As shown in Fig. 1d and Additional file 2: Figure S2, the signal intensity of IL-33 in dermal fibroblasts was remarkably increased in BLM-treated Fli1+/− mice as compared with BLM-treated WT mice, whereas that in epidermal keratinocytes was comparable. This evidence concerns the gene IL33 and Bloom syndrome.